跳至主要内容
临床试验/CTRI/2023/04/051589
CTRI/2023/04/051589招募中3 期

Effect of low dose intravenous Ketamine on Delayed Cerebral Ischemia and long-term outcome in aneurysmal Subarachnoid Haemorrhage patients – A Randomised Controlled Trial

ISNACC0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All aSAH patients 18-70 years of age
  • 2.Admitted to the hospital within 72 hours of ictus
  • 3.Ruptured anterior cerebral circulation aneurysm with subarachnoid hemorrhage on admission cranial computed tomography (CT) scan with modified Fisher grade of 3-4
  • 4.World Federation of Neurological Surgeons (WFNS) grade 1 to 3
  • 5.Informed Consent for participation in the study

排除标准

  • 1.Refusal of consent
  • 2.Patients with multiple aneurysms
  • 3.Baseline Systolic Blood Pressure (SBP) >200 mm Hg
  • 4.Patients with intraoperative iatrogenic injury or inadvertent clipping of intracranial arteries
  • 5.Any contraindication for the use of ketamine like acute psychosis, previous known ischemic heart diseases.
  • 6.Mean arterial pressure (MAP) increases by more than 20% from baseline (on that day) following infusion

研究者

发起方
ISNACC

相似试验